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Abstract
Allosteric transcription factors undergo binding events both at their inducer binding sites as well as
at distinct DNA binding domains, and it is often difficult to disentangle the structural and functional
consequences of these two classes of interactions. In this work, we compare the ability of two statistical
mechanical models – the Monod-Wyman-Changeux (MWC) and the Koshland-Ne´methy-Filmer (KNF)
models of protein conformational change – to characterize the multi-step activation mechanism of the
broadly acting cyclic-AMP receptor protein (CRP). We first consider the allosteric transition resulting
from cyclic-AMP binding to CRP, then analyze how CRP binds to its operator, and finally investigate
the ability of CRP to activate gene expression. In light of these models, we examine data from a beautiful
recent experiment that created a single-chain version of the CRP homodimer, thereby enabling each
subunit to be mutated separately. Using this construct, six mutants were created using all possible
combinations of the wild type subunit, a D53H mutant subunit, and an S62F mutant subunit. We
demonstrate that both the MWC and KNF models can explain the behavior of all six mutants using a
small, self-consistent set of parameters. In comparing the results, we find that the MWC model slightly
outperforms the KNF model in the quality of its fits, but more importantly the parameters inferred by
the MWC model are more in line with structural knowledge of CRP. In addition, we discuss how the
conceptual framework developed here for CRP enables us to not merely analyze data retrospectively, but
has the predictive power to determine how combinations of mutations will interact, how double mutants
will behave, and how each construct would regulate gene expression.
Introduction
Cyclic-AMP receptor protein (CRP; also known as the catabolite receptor protein, CAP) is an allosteric
transcription factor that regulates over 100 genes in Escherichia coli (1–4). Upon binding to cyclic-AMP
(cAMP), the homodimeric CRP undergoes a conformational change whereby two alpha helices reorient
to open a DNA binding domain (5), allowing CRP to bind to DNA and affect transcription (6–8). While
much is known about the molecular details of CRP and how different mutations modify its functionality
(9, 10), each new CRP mutant is routinely analyzed in isolation using phenomenological models. We
argue that given the hard-won structural insights into the conformational changes of proteins like CRP,
it is important to test how well mechanistically motivated models of such proteins can characterize the
wealth of available data.
One of the difficulties inherent in understanding allosteric transcription factors such as CRP lies in our
inability to disentangle the numerous processes involved in transcription, such as the binding of cAMP
to CRP, of CRP to DNA, and of transcription regulation as shown in Fig. 1(A). Measurements of gene
expression depend upon all of these processes, and mechanistic statements about the individual steps
must necessarily be inferred (11–14). To this end, in vitro studies are beginning to probe each binding
event separately, providing a testbed to refine our understanding of both allostery and transcriptional
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Figure 1. Key parameters governing CRP function. (A) Within the MWC and KNF models,
each CRP subunit can assume either an active or an inactive conformation with a free energy difference
 between the two states. cAMP can bind to CRP (with a dissociation constant MAD in the active state
and M ID in the inactive state) and promotes the active state (M
A
D < M
I
D in the MWC model; M
I
D →∞
in the KNF model). Active CRP has a higher affinity for the operator (LAD) than the inactive state
(LID). When CRP is bound to DNA, it promotes RNA polymerase binding through an interaction
energy P , thereby enhancing gene expression. (B) Lanfranco et al. constructed a single-chain CRP
molecule whose two subunits could be mutated independently. They measured the cAMP and DNA
binding affinity for CRP mutants comprised of wild type (WT), D (D53H), or S (S62F) subunits.
activation.
Our paper is inspired by a recent in vitro study of CRP performed by Lanfranco et al. who separately
measured the two binding events of CRP, first to cAMP and then to DNA (15), providing an opportunity
to make a rigorous, quantitative analysis of the allosteric properties of CRP. To this end, we explore
two mechanistic frameworks for the allosteric transition of CRP: the Monod-Wyman-Changeux (MWC)
model, which posits that both CRP subunits fluctuate concurrently between an active and inactive
conformational state (16), and the Koshland-Ne´methy-Filmer (KNF) model, which proposes that each
subunit must independently transition from an inactive to active state upon ligand binding (17). Although
the MWC model provides a marginally better characterization of the data, the two models offer different
interpretations of the general behavior of CRP. For example, the parameter set we inferred for the KNF
model predicts that CRP will bind equally well to DNA regardless of whether it is bound to one or two
cAMP molecules, while the MWC model predicts that singly bound CRP will bind more tightly to DNA
than unbound and doubly bound CRP. Knowledge of the structure of CRP is in line with the MWC
predictions (10, 18), demonstrating that a model should not be judged merely by its goodness of fit, but
rather by the interpretation of its fit parameters compared with the available knowledge of the system.
In addition to their consideration of the wild type protein, Lanfranco et al. engineered a single-chain
CRP molecule whose two subunits are tethered together by an unstructured polypeptide linker. This
construct enabled them to mutate each subunit independently as shown in Fig. 1(B), providing a novel
setting within which to analyze the combinatorial effects of mutations. Specifically, they took three
distinct CRP subunits – the wild type subunit and the well characterized mutations D53H and S62F
originally chosen to perturb the transcription factor’s cAMP binding domain (19, 20) – and linked them
together in every possible combination to create six CRP mutants.
The effects of mutations are often difficult to interpret, and indeed the results from Lanfranco et
al. showed no clear pattern. The behavior of each mutant was analyzed independently by fitting its
binding curve to a second order polynomial, but this analysis was unable to make use of the fact that the
six CRP mutants are linked through their subunit compositions (15). In this work, we aim to close that
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gap by constructing a quantitative framework that can describe the full suite of CRP data by utilizing
the subunit composition of CRP.
This concrete link between the composition and behavior of CRP mutants raises the question of
whether the response of a mutant can be predicted based on the behavior of closely related mutants.
For example, given sufficient data of CRP with two wild type (WT) subunits and of CRP with two
D53H subunits, can we predict how a CRP comprised of one wild type and one D53H subunit will
behave? More generally, can the behavior of the symmetric mutants (top row of Fig. 1(B)) predict the
behavior of the asymmetric mutants (bottom row of Fig. 1(B))? We demonstrate that both the MWC
and KNF models can generate such predictions. These results suggest a way to harness the combinatorial
complexity of oligomeric proteins and present a possible step towards systematically probing the space
of mutations.
We end by exploring the physiological impact of these CRP mutants by considering how they would
promote gene expression in vivo. Because CRP is a global activator, its activity within the cell is
tightly regulated by enzymes that produce, degrade, and actively transport cAMP. We discuss how
these processes can either be modeled theoretically or excised experimentally and calibrate our resulting
framework for transcription using gene expression measurements for wild type CRP (7). In this manner,
we find a small, self-consistent set of parameters able to characterize each step of CRP activation shown
in Fig. 1(A).
The remainder of this paper is organized as follows. First, we characterize the interaction between
cAMP and CRP for the six CRP mutants created by Lanfranco et al. and quantify the key parameters
governing this behavior. Next, we analyze the interaction between CRP and DNA from the perspectives
of the MWC and KNF models and discuss how the interpretations of the parameters inferred by the
MWC model are more in line with structural knowledge of the system. Finally, we consider how CRP
enhances gene expression and extend the results from Lanfranco et al. to predict the activation profiles
of the CRP mutants within a cellular environment.
Results and Discussion
The Interaction between CRP and cAMP
In this section, we examine the cAMP-CRP binding process through the lenses of the MWC and KNF
models. We find that both models can characterize data from a suite of CRP mutants using a compact
set of parameters, thereby highlighting how each mutant’s behavior is tied to its subunit composition.
MWC Model
We first formulate a description of cAMP-CRP binding using the MWC model, where the two subunits
of each CRP molecule fluctuate concurrently between an active and inactive state. We define the free
energy difference between the inactive and active conformations to be  per subunit, so that the total
free energy difference between inactive CRP and active CRP is 2. The different conformations of
CRP binding to cAMP and their corresponding Boltzmann weights are shown in Fig. 2(A). For each
cAMP-CRP dissociation constant MYX , the subscript denotes which CRP subunit it describes – either
the left (L) or right (R) subunit – while the superscript denotes the active (A) or inactive (I) state of
CRP. Given a cAMP concentration [M ], the fraction of occupied cAMP binding sites is given by
fractional CRP occupancy([M ]) =
1
2
(
[M ]
MAL
+ [M ]
MAR
)
+ [M ]
MAL
[M ]
MAR
+ 12e
−2β
(
[M ]
MIL
+ [M ]
MIR
)
+ e−2β [M ]
MIL
[M ]
MIR(
1 + [M ]
MAL
)(
1 + [M ]
MAR
)
+ e−2β
(
1 + [M ]
MIL
)(
1 + [M ]
MIR
) .
(1)
Here, the fractional occupancy of CRP bound to zero, one, or two cAMP equals 0, 1/2, and 1, respectively.
Experimentally, the fractional occupancy was measured using ANS fluorescence which utilizes a fluorescent
probe triggered by the conformational change of cAMP binding to CRP (15). We note that this
measurement was carried out in vitro in the absence of DNA.
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Figure 2. Macroscopic states and Boltzmann weights for cAMP binding to CRP. (A)
Within the MWC model, cAMP (purple circles) may bind to a CRP subunit in either the active (dark
green) or inactive (light green) state. MAL and M
I
L represent the dissociation constants of the left
subunit in the active and inactive states, respectively, while MAR and M
I
R represent the analogous
dissociation constants for the right subunit. [M ] denotes the concentration of cAMP and  represents
the free energy difference between each subunit’s inactive and active states. (B) The KNF model
assumes that the two CRP subunits are inactive when unbound to cAMP and transition to the active
state immediately upon binding to cAMP. The parameters have the same meaning as in the MWC
model, but states where one subunit is active while the other is inactive are allowed.
Table 1. Parameters for cAMP binding to CRP. The data in Fig. 3 can be characterized using a
single set of dissociation constants for the WT, D, and S subunits whose values and standard errors are
shown. The left column corresponds to the MWC parameters given in Eq. 1 while the right column
corresponds to the KNF model given by Eq. 6. For both models, the data only constrains the parameter
combination M˜AX = M
A
Xe
−β. The effective dissociation constant of the S subunit in the MWC model
can only be bounded from below as M˜AS ≥ 1000× 10−6 M.
MWC Parameter Best-Fit Value KNF Parameter Best-Fit Value
M˜AWT, M
I
WT {25± 1, 40± 3} × 10−6 M M˜AWT (20± 2)× 10−6 M
M˜AD , M
I
D {10± 1, 50± 5} × 10−6 M M˜AD (10± 1)× 10−6 M
M˜AS , M
I
S {≥ 1000, 200± 10} × 10−6 M M˜AS (220± 10)× 10−6 M
Lanfranco et al. considered CRP subunits with either the D53H or S62F point mutations (hereafter
denoted by D and S, respectively), with the D subunit binding more strongly to cAMP than the wild
type while the S subunit binds more weakly as shown in Fig. 3(A). While we could characterize the
dose-response curves of each CRP mutant independently – for example, by using Eq. 1 to extract a set of
parameters for each mutant – such an analysis lacks a direct connection between the subunit composition
and the corresponding binding behavior. Instead, we assume that the cAMP binding affinity for each
subunit should be uniquely dictated by that subunit’s identity as either the WT, D, or S subunit. To that
end, we represent the fractional occupancy of CRPD/WT using Eq. 1 with one D subunit (M
A
L = M
A
D ,
M IL = M
I
D) and one WT subunit (M
A
R = M
A
WT, M
I
R = M
I
WT). The equations for the remaining CRP
mutants follow analogously, tying the behavior of each mutant to its subunit composition.
Many studies have been conducted upon cAMP-CRP binding using a broad range of methods
including equilibrium dialysis, fluorescence assays, and protease digestion, but the resulting parameters
inferred from these experiments have varied widely (19). Estimates on the free energy difference 2
between inactive and active CRP range from approximately −20 kBT to −10 kBT (10, 21, 22) while
apparent dissociation between cAMP and CRPWT/WT range from 10
−6-10−3 M (19, 23, 24).
Part of the difficulty in pinning down these values stems from the fact that degenerate parameter
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Figure 3. cAMP binding curves for different CRP mutants. In addition to the wild type CRP
subunit (denoted WT), the mutation D53H (denoted D) and the mutation S62F (denoted S) can be
applied to either subunit as indicated by the subscripts in the legend. (A) Curves were characterized
using the MWC model, Eq. 1. The D subunit increases CRP’s affinity for cAMP while the S subunit
decreases this affinity. (B) Asymmetrically mutating the two subunits results in distinct cAMP binding
curves. The data for the WT/D mutant lies between the WT/WT and D/D data in Panel (A), and
analogous statements apply for the WT/S and D/S mutants. (C) The symmetric mutants and (D) the
asymmetric mutants can also be analyzed using the KNF model, Eq. 6, resulting in curves that are
similar to those found by the MWC model. The (corrected) sample standard deviation√
1
n−1
∑n
j=1(y
(j)
theory − y(j)data)2 equals 0.03 for the MWC model and 0.06 for the KNF model, and the
best-fit parameters for both models are given in Table 1.
values reproduce equivalent binding curves. For instance, it is known that in the absence of cAMP, the
overwhelming majority of CRP molecules will be in the inactive state (1 e−2β). Intuitively, there will
effectively be no active CRP molecules in the absence of cAMP regardless of whether 2 = −10 kBT
or 2 = −20 kBT ; however, in the presence of saturating cAMP the latter case will require a larger
affinity between active CRP and cAMP (smaller MAL and M
A
R ) to compensate for this greater free energy
difference. The same cAMP-CRP binding curves can even be produced for an arbitrarily large and
negative free energy difference (→ −∞) provided that the dissociation constants scale appropriately.
This scaling can be determined by fixing the ratio of doubly-cAMP bound CRP in the active state
( [M ]
MAL
[M ]
MAL
) and inactive state (e−2β [M ]
MIL
[M ]
MIR
). For the CRP system this requires that M IL and M
I
R do not
depend on  while MAL ,M
A
R ∝ eβ. Mathematically, in the limit of a large and negative  the cAMP
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occupancy becomes
fractional CRP occupancy([M ]) =
1
2e
β
(
[M ]
M˜AL
+ [M ]
M˜AR
)
+ [M ]
M˜AL
[M ]
M˜AR
+ 12
(
[M ]
MIL
+ [M ]
MIR
)
+ [M ]
MIL
[M ]
MIR(
eβ + [M ]
M˜AL
)(
eβ + [M ]
M˜AR
)
+
(
1 + [M ]
MIL
)(
1 + [M ]
MIR
)
≈
[M ]
M˜AL
[M ]
M˜AR
+ 12
(
[M ]
MIL
+ [M ]
MIR
)
+ [M ]
MIL
[M ]
MIR
[M ]
M˜AL
[M ]
M˜AR
+
(
1 + [M ]
MIL
)(
1 + [M ]
MIR
) , (2)
where in the first equality we multiplied the numerator and denominator of Eq. 1 by e2β and defined
the effective dissociation constants
M˜AL = e
−βMAL , (3)
and
M˜AR = e
−βMAR , (4)
while in the latter equality of Eq. 2 we neglected all of the terms multiplied by the small quantity eβ
(which is equivalent to taking the zeroth order Taylor series about e−β ≈ 0). In Supporting Information
Section A, we demonstrate how the  parameter may be shifted arbitrarily without altering the cAMP-
CRP binding curves provided Eqs. 3 and 4 hold and that 2 . −3 kBT (above which the approximation
1 e−2β breaks down). This last assumption is well justified, since the overwhelming majority of CRP
molecules assume the inactive conformation in the absence of cAMP (10). Therefore, the maximum
information that can be extracted from the data includes the inactive CRP-cAMP dissociation constants
M IL and M
I
R and the effective dissociation constants M˜
A
L and M˜
A
R . Lastly, we note that if the D and S
mutations alter the free energy , that effect will be absorbed into the effective dissociation constants.
Using Eq. 2, we can extract the set of effective dissociation constants for the WT, D, and S subunits
that determine the behavior of all six CRP mutants. The resulting parameters (shown in Table 1) give
rise to the cAMP-CRP binding curves in Fig. 3(A) and (B). In Supporting Information Section B, we
demonstrate that the symmetric CRP mutants in Fig. 3(A) provide sufficient information to predict
the behavior of the asymmetric mutants in Fig. 3(B). We further show that fitting each CRP data
set individually to the MWC or KNF models without constraining the WT, D, and S subunits to a
single unified set of dissociation constants results in only a marginal improvement over the constrained
fitting. Finally, we analyze the slope of each cAMP binding response and explain why they are nearly
identical for the six CRP mutants. Supporting Information Section C investigates the effects of the
double mutation D+S on a single subunit.
KNF Model
We now turn to a KNF analysis of CRP, where the two subunits are individually inactive when not
bound to cAMP and become active upon binding as shown in Fig. 2(B). Some studies have claimed that
cAMP binding to one CRP subunit does not affect the state of the other subunit, in support of the KNF
model (25). Other studies, meanwhile, have reported that a fraction of CRP molecules are active even in
the absence of cAMP, thereby favoring an MWC interpretation (9). It is not yet known whether either
model can accurately represent the system. To that end, we explore some of the consequences of a KNF
interpretation of CRP.
Using the statistical mechanical states of the system in Fig. 2(B), the occupancy of CRP is given by
fractional CRP occupancy([M ]) =
e−β
2
(
[M ]
MAL
+ [M ]
MAR
)
+ [M ]
MAL
[M ]
MAR(
e−β + [M ]
MAL
)(
e−β + [M ]
MAR
) . (5)
Note that by multiplying the numerator and denominator by e2β and defining the same effective
dissociation constants (Eqs. 3 and 4) as for the MWC model, we can eliminate the free energy difference
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 to obtain the form
fractional CRP occupancy([M ]) =
1
2
(
[M ]
M˜AL
+ [M ]
M˜AR
)
+ [M ]
M˜AL
[M ]
M˜AR(
1 + [M ]
M˜AL
)(
1 + [M ]
M˜AR
) . (6)
This simplification occurs because within the KNF model, a CRP monomer only switches from the
inactive to active state upon cAMP binding. As a result, the free energy of cAMP binding to CRP
and the free energy of the CRP undergoing its inactive-to-active state conformational always occur
concurrently and may be combined into the effective dissociation constants M˜AL and M˜
A
R . As shown in
Fig. 3(C) and Fig. 3(D), the KNF model can characterize the six mutant CRP binding curves, albeit with
a larger sample standard deviation than the MWC model. While the KNF model has fewer parameters,
the cost of this simplicity is manifest in its slightly poorer fits.
The Interaction between CRP and DNA
We now turn to the second binding interaction experienced by CRP, namely, that between CRP and
DNA within the MWC and KNF models.
MWC Model
Consider a concentration [L] of CRP whose subunits either assume an active state (where they tightly
bind to DNA with a dissociation constant LA) or in an inactive state (characterized by weaker DNA
binding with dissociation constant LI satisfying LI > LA). The states and weights of this system within
the MWC model are shown in Fig. 4(A).
Lanfranco et al. fluorescently labeled a short, 32 bp DNA sequence which binds to CRP. Using a
spectrometer, they measured the anisotropy of this fluorescence when different concentrations of CRP
and cAMP were added in vitro (15). The data are shown in Fig. 5(A) for CRPD/S. When CRP binds, it
slows the random tumbling of the DNA so that over very short time scales the fluorescence is oriented
along a particular axis, resulting in a larger anisotropy readout. Unbound DNA is defined as having
anisotropy = 1 while DNA-bound CRP with 0, 1, or 2 bound cAMP have higher anisotropies of 1 + r0,
1 + r1, and 1 + r2, respectively. Thus, the total anisotropy within the model is given by the weighted
sum of each species (27), namely,
anisotropy = 1 + r0p0 + r1p1 + r2p2. (7)
Here, p0, p1, and p2 represent the probability that DNA-bound CRP will be bound to 0, 1, and 2 cAMP
molecules, respectively. In this model, we have extended the classic MWC model to allow each of these
states to have a unique DNA binding affinity. Using the effective dissociation constants (Eqs. 3 and 4)
and neglecting all terms proportional to the small quantity eβ, we can write these probabilities as
p0 =
e2β [L]LA +
[L]
LI
Z
≈
[L]
LI
Z
, (8)
p1 =
e2β [L]LA
(
[M ]
MAL
+ [M ]
MAR
)
+ [L]LI
(
[M ]
MIL
+ [M ]
MIR
)
Z
≈
[L]
LI
(
[M ]
MIL
+ [M ]
MIR
)
Z
, (9)
and
p2 =
e2β [L]LA
[M ]
MAL
[M ]
MAR
+ [L]LI
[M ]
MIL
[M ]
MIR
Z
≈
[L]
LA
[M ]
M˜AL
[M ]
M˜AR
+ [L]LI
[M ]
MIL
[M ]
MIR
Z
(10)
with
Z = e2β
(
1 +
[L]
LA
)(
1 +
[M ]
MAL
)(
1 +
[M ]
MAR
)
+
(
1 +
[L]
LI
)(
1 +
[M ]
M IL
)(
1 +
[M ]
M IR
)
≈
(
1 +
[L]
LA
)
[M ]
M˜AL
[M ]
M˜AR
+
(
1 +
[L]
LI
)(
1 +
[M ]
M IL
)(
1 +
[M ]
M IR
)
. (11)
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Figure 4. States and weights for CRP binding to DNA. (A) The DNA unbound states from
Fig. 2 together with the DNA bound states. The Boltzmann weight of each DNA bound state is
proportional to the concentration [L] of CRP and inversely proportional to the CRP-DNA dissociation
constants LA or LI for the active and inactive states, respectively. (B) In the KNF model, these same
parameters apply to each CRP subunit which can be independently active or inactive.
In making these approximations, we have assumed the stricter conditions e2β LILA  1 and e2β LILA
MIX
M˜AX
 1
for the WT, D, and S subunits, all of which are valid assumptions for this system (see Supporting
Information Section A).
Fig. 5(A) shows the resulting best-fit curves for the anisotropy data, with the corresponding CRPD/S
DNA dissociation constants given in Table 2. Since 1 + r0 ≈ 1, unbound CRP binds poorly to DNA, in
accordance with the inactive state crystal structure whose DNA recognition helices are buried inside
the protein (10). Additionally, the anisotropy 1 + r1 = 1.7 of the DNA-CRP-cAMP complex is larger
than that of both the unbound state and the doubly bound state DNA-CRP-(cAMP)2 with 1 + r2 = 1.4;
this suggests that CRP-(cAMP)2 binds more weakly to DNA that CRP-cAMP. Previous studies have
confirmed this claim using multiple experimental methods including proteolytic digestion by subtilisin,
chemical modification of Cys-178, and fluorescence measurements (18, 28), although other work has
proposed an alternate explanation that above millimolar cAMP concentrations CRP attains new states
with highly unfavorable DNA binding affinities (13, 29). In Supporting Information Section D, we extend
the analysis of CRP-DNA binding to the remaining CRP mutants.
KNF Model
We now turn to the KNF model of DNA binding where each CRP subunit is inactive when not bound
to cAMP and active when bound to cAMP as shown in Fig. 4(B). As in the MWC model, LA and LI
represent the dissociation constants between DNA and CRP in the active and inactive states, respectively.
The mixed state of DNA-bound CRP with one active and one inactive subunit has a dissociation constant
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Figure 5. The interaction between CRP and DNA. (A) Anisotropy of 32-bp fluorescein-labeled
lac promoter binding to CRPD/S at different concentrations of cAMP. An anisotropy of 1 corresponds to
unbound DNA while higher values imply that DNA is bound to CRP. (B) This same data analyzed
using the KNF model. In the presence of cAMP, more CRP subunits will be active, and hence there will
be greater anisotropy for any given concentration of CRP. The sample standard deviation√
1
n−1
∑n
j=1(y
(j)
theory − y(j)data)2 is 0.01 for both the MWC and KNF models, with the corresponding
parameters given in Tables 1 and 2.
Table 2. Parameters for CRP binding to DNA. The anisotropy data for CRPD/S characterized
using Eq. 7, as shown in Fig. 5. Each value is given as a mean ± standard error. The uncertainty in M˜AS
parameter (shown in Table 1) leads to a corresponding uncertainty in the active CRP dissociation
constant LA.
MWC Parameter Best-Fit Value KNF Parameter Best-Fit Value
r0, r1, r2 {0.1, 0.8, 0.5} ± 0.1 r0, r1, r2 {0.1, 0.5, 0.5} ± 0.1
LA, LI {≤ 30, 30± 10} × 10−9 M LA, LI {20± 10, 30± 20} × 10−9 M
√
LALI (see Supporting Information Section E). The anisotropy within the KNF model is given by Eq. 7
with
p0 =
[L]
LI
Z
, (12)
p1 =
[L]√
LALI
(
[M ]
M˜AL
+ [M ]
M˜AR
)
Z
, (13)
and
p2 =
[L]
LA
[M ]
M˜AL
[M ]
M˜AR
Z
(14)
representing the probabilities of the DNA-CRP, DNA-CRP-cAMP, and DNA-CRP-(cAMP)2 states,
respectively, with
Z =
(
1 +
[M ]
M˜AL
)(
1 +
[M ]
M˜AR
)
+
[L]
LI
(
1 +
[M ]
M˜AL
√
LI
LA
)(
1 +
[M ]
M˜AR
√
LI
LA
)
. (15)
Fig. 5(B) shows the characterization of the anisotropy data using the KNF model with the corre-
sponding parameters given by the right column of Table 2. Unlike the MWC model, the best-fit KNF
anisotropy parameters satisfy r1 ≈ r2, suggesting that CRP binds equally tightly to DNA independent of
how many cAMP are bound to it. Structural understanding of CRP support the MWC characterization,
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DESCRIPTION WEIGHT
Figure 6. States and weights for a simple activation motif. Binding of RNAP (blue) to a
promoter is facilitated by the binding of the activator CRP. Simultaneous binding of RNAP and CRP is
facilitated by an interaction energy P,LA for active CRP (dark green) and P,LI for inactive CRP (light
green). cAMP (not drawn) influences the concentration of active and inactive CRP as shown in Fig. 4.
as both unbound and doubly bound CRP have been reported to have a significantly lower DNA-binding
affinity than singly-cAMP bound CRP (18, 28).
Implications of Mutations for in vivo Systems
CRP is a global transcriptional activator which governs many metabolic genes in E. coli (8). It is
interesting to consider how the mutants characterized in the Lanfranco et al. experiments would behave as
transcriptional activators for in vivo gene expression measurements. In this section, we make predictions
for how CRP will act in vivo for the different mutants characterized above. To focus our analysis, we
use the MWC model presented above to analyze gene expression measurements of a system where CRP
is the only transcription factor present, although it is straightforward to generalize to more complex
regulatory architectures or to apply the KNF framework to this process (30).
Simple Activation
As above, consider a cell with cAMP concentration [M ] and CRP concentration [L] where the population
of CRP is split between an active [LA] and an inactive [LI ] conformation. Suppose the cell has a
concentration [P ] of RNA polymerase (RNAP) which have a dissociation constant PD with a promoter
of interest. The thermodynamic states of the system are shown in Fig. 6, where the activator can bind
to and recruit RNAP via an interaction energy P,LA between active CRP and RNAP with a weaker
interaction P,LI between inactive CRP and RNAP. Without these two interaction energies, the RNAP
and CRP binding events would be independent and there would be no activation.
We assume that gene expression is equal to the product of the RNAP transcription rate rtrans and
the probability that RNAP is bound to the promoter of interest, namely,
activity = rtrans
[P ]
PD
(
1 + [LI ]LI e
−βP,LI + [LA]LA e
−βP,LA
)
[P ]
PD
(
1 + [LI ]LI e
−βP,LI + [LA]LA e
−βP,LA
)
+ 1 + [LI ]LI +
[LA]
LA
. (16)
Several additional factors influence gene expression in vivo. First, cAMP is synthesized endogenously
by cya and degraded by cpdA, although both of these genes have been knocked out for the data set
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Figure 7. Predicted gene expression profiles for a simple activation architecture. Gene
expression for wild type CRP (green dots from Ref. (7)), where 1 Miller Unit (MU) represents a
standardized amount of β-galactosidase activity. This data was used to determine the relevant
parameters in Eq. 16 for the promoter in the presence of [L] = 1.5µM of CRP (33). The predicted
behavior of the CRP mutants is shown using their corresponding cAMP dissociation constants.
Parameters used were [P ]PD = 130× 10−6, rtrans = 5× 105 MUhr , γ = 0.1, P,LA = −3 kBT , P,LI = 0 kBT ,
and those shown in Tables 1 and 2.
shown in Fig. 7 (see Methods and Ref. (7)). Furthermore, cAMP is actively transported out of a cell
leading to a smaller concentration of intracellular cAMP. Following Kuhlman et al., we will assume that
the intracellular cAMP concentration is proportional to the extracellular concentration, namely, γ[M ]
(with 0 < γ < 1) (31, 32). Hence, the concentration of active CRP satisfies [LA][L] = p
L
act(γ[M ]) where the
fraction of active CRP pLact is given by Fig. 2(A) as
pLact([M ]) =
(
1 + [M ]
MAL
)(
1 + [M ]
MAR
)
(
1 + [M ]
MAL
)(
1 + [M ]
MAR
)
+ e−2β
(
1 + [M ]
MIL
)(
1 + [M ]
MIR
) ≈ [M ]M˜AL [M ]M˜AR
[M ]
M˜AL
[M ]
M˜AR
+
(
1 + [M ]
MIL
)(
1 + [M ]
MIR
) .
(17)
In the last step, we have again introduced the effective dissociation constants from Eqs. 3 and 4 and
dropped any terms proportional to e−β. In addition to these considerations, proteins in vivo may
experience crowding, additional forms of modification, and competition by other promoters. However,
since our primary goal is to understand how CRP mutations will affect gene expression, we proceed with
the simplest model and neglect the effects of crowding, modification, and competition.
Because of the uncertainty in the dissociation constant LA between active CRP and DNA (see
Table 2), it is impossible to unambiguously determine the transcription parameters from the single data
set for wild type CRP shown in Fig. 7. Instead, we select one possible set of parameters ( [P ]PD = 130×10−6,
rtrans = 5× 105 MUhr , γ = 0.1, P,LA = −3 kBT , and P,LI = 0 kBT ) that is consistent with the wild type
data. Next, we inserted the other cAMP-CRP dissociation constants (given in Table 1) into Eq. 16
to predict the gene expression profiles of the CRP mutants. Fig. 7 show the possible behavior of the
CRPD/D and CRPWT/D mutants. As expected, replacing a WT subunit with a D subunit shifts the gene
expression profile leftwards since the D subunit has a higher cAMP affinity (see Fig. 3(A)). Interestingly,
the substitution of WT with D subunits comes with a concomitant increase in the maximum gene
expression because at saturating cAMP concentrations, a larger fraction of CRPD/D is active compared
to CRPWT/WT (96% and 68%, respectively) as seen by using Eq. 17 and the parameters in Table 1.
Note that we cannot predict the behavior of any of the CRP mutants with S subunits due to the large
uncertainty in M˜AS .
Lastly, we probe the full spectrum of phenotypes that could arise from the activity function provided
in Eq. 16 for any CRP mutant by considering all possible values of the cAMP-CRP dissociation constants
MAL , M
I
L, M
A
R , and M
I
R in Eq. 17. In particular, we relax our assumption that cAMP binding promotes
the CRP’s active state, as a CRP mutation may exist whose inactive state binds more tightly to cAMP
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Figure 8. The spectrum of input-output responses for mutant CRP in a simple activation
architecture. The possible gene expression profiles given by Eq. 16 can be categorized based upon the
cAMP-CRP binding affinity in each subunit. In all cases, we assumed MAL = M
A
R = 3× 10−6 M. The
activation response (blue) was generated using M IL = M
I
R = 6× 10−6 M. The repression response
(orange) used M IL = M
I
R = 10
−7 M. The peaked response (gold) used M IL = 10
−7 M and
M IR = 300× 10−6 M. The flat response used M IL = M IR = 3× 10−6 M. The remaining parameters were
the same as in Fig. 7 together with  = −3 kBT .
than its active state. Fig. 8 demonstrates that given such a mutation, a variety of novel phenotypes may
arise. The standard sigmoidal activation response is achieved when cAMP binding promotes the active
state in both CRP subunits (MAL < M
I
L, M
A
R < M
I
R). A repression phenotype is achieved in the opposite
extreme when cAMP binding favors the inactive CRP state (MAL > M
I
L, M
A
R > M
I
R). When one subunit
is activated and the other is repressed by cAMP (MAL < M
I
L, M
A
R > M
I
R or M
A
L > M
I
L, M
A
R < M
I
R),
a peaked response can form. If the CRP subunits have the same affinity for cAMP in the active and
inactive states (MAL = M
I
L or M
A
R = M
I
R), then CRP will behave identically for all concentrations of
CRP, generating a flat-line response. It will be interesting to see whether these phenotypes can be
achieved experimentally.
Conclusion
The recent work of Lanfranco et al. provides a window into the different facets of gene regulation through
activation (15). Using insights from their in vitro experiments, we can break down the process of
activation into its key steps, namely: (1) the binding of cAMP to make the activator CRP competent to
bind DNA (Fig. 3); (2) the binding of CRP to DNA (Fig. 5); and (3) the recruitment of RNAP to promote
gene expression (Fig. 7). By concurrently modeling these processes, we begin to unravel relationships
and set strict limits for the binding energies and dissociation constants governing these systems. One
hurdle to precisely fixing these values for CRP has been that many different sets of parameters produce
the same degenerate responses (see Supporting Information Section A). This parameter degeneracy is
surprisingly common when modeling biological systems (34, 35), and we discuss how to account for it
within the MWC and KNF models of CRP. A key feature of our analysis is that it permits us to identify
the relevant parameter combinations for the system, quantify how well we can infer their values, and
suggest which future experiments should be pursued to best constrain the behavior of the system.
Lanfranco et al. further explored how mutations in the cAMP binding domain of one or both subunits
of CRP would influence its behavior. Specifically, they used three distinct subunits (WT, D, and S) to
create the six CRP mutants shown in Fig. 1(B). We analyzed these constructs using both the Monod-
Wyman-Changeux and Koshland-Ne´methy-Filmer models of molecular switching and demonstrated that
either model can characterize all six mutants using a self-consistent framework where each subunit is
described by a unique cAMP dissociation constant (see Table 1). However, these two models cannot be
deemed successful simply because they yield curves that can reproduce the data; the benefit of using
mechanistic models involving physical parameters is that the inferred values can be cross-checked against
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other sources. For instance, the MWC model predicts that singly cAMP-bound CRP will bind more
tightly to DNA than unbound or doubly bound CRP, in line with the structural knowledge of the system
(10, 18, 28). And while the KNF model can reproduce nearly identical CRP-DNA binding curves to
those generated by the MWC model, its inferred parameters imply that CRP should bind equally well to
its operator regardless of whether it is singly or doubly bound to cAMP (see Table 2). Overall, these
results favor an MWC interpretation of the CRP system.
The models presented here suggest several avenues to further our understanding of CRP. First,
several groups have proposed that multiple CRP mutations (K52N, T127, S128, G141K, G141Q, A144T,
L148K, H159L from Refs. (9, 36, 37)) only affect the free energy difference  between the CRP subunit’s
active and inactive states while leaving the cAMP-CRP dissociation constants unchanged. It would be
interesting to test the framework developed here across CRP mutants specifically designed to vary these
parameters, since the  dependence of the system is completely relegated to the effective dissociation
constants (see Eqs. 3 and 4).
Second, the MWC and KNF models can be used to predict how the CRP mutants generated by
Lanfranco et al. would behave in vivo. We calibrated the CRPWT/WT gene expression profile using data
from Ref. (7) and suggested how the remaining CRP mutants may function within a simple activation
regulatory architecture given the currently available data (see Fig. 7). It would be interesting to measure
such constructs within the cell and test the intersection of our in vivo and in vitro understanding both
in the realm of the multi-step binding events of CRP as well as in quantifying the effects of mutations.
Finally, we note that both the MWC and KNF models can serve as a springboard for more complex
descriptions of CRP. It has been debated whether the first cAMP binding event inhibits a second cAMP
from binding or if doubly bound CRP has a weaker affinity to DNA (13, 18, 27, 38, 39), and such
modifications are straightforward to add to the models discussed above. However, a key advantage of
the simple frameworks presented here lies in their ability to predict how different CRP subunits combine.
For example, in Supplementary Information Section B we demonstrate how the data from the three
symmetric CRP mutants in Fig. 3(A) can be used to characterize the asymmetric mutants in Fig. 3(B).
It would be interesting to see whether such predictions continue to hold as more mutant subunits are
characterized. Such a framework has the potential to harness the combinatorial complexity of oligomeric
proteins and presents a possible step towards systematically probing the space of mutations.
Methods
As described in Ref. (15), the fractional CRP occupancy data in Fig. 3 was measured in vitro using
8-anilino-1-naphthalenesulfonic acid (ANS) fluorescence which is triggered by the conformational change
of cAMP binding to CRP. The CRP-DNA anisotropy data in Fig. 5 was measured in vitro by tagging the
end of a 32 bp lac promoter with a fluorescein molecule and measuring its anisotropy with a spectrometer.
When CRP is bound to DNA, anisotropy arises from two sources: the fast bending of the flanking DNA
sequence and the slower rotation of the CRP-DNA complex. Sources of error include oligomerization of
CRP, the bending of the flanking DNA, and nonspecific binding of CRP to the DNA.
The in vivo gene expression data was taken from Kuhlman et al. using the lac operon E. coli strain
TK310 (7). This strain had two genes knocked out: cya (a gene encoding adenylate cyclase, which
endogenously synthesizes cAMP) and cpdA (encoding cAMP-phosphodiesterase, which degrades cAMP
within the cell). Experiments were done at saturating concentrations of inducer ([IPTG] = 1 mM) so
that Lac repressor negligibly binds to the operator. In this limit, the only transcription factor affecting
gene expression is the activator CRP. Gene expression was measured using β-galactosidase activity.
Supporting Material
Supporting Materials with the aforementioned derivations are available online together with a Mathe-
matica notebook that contains all the data, reproduces the fitting (using both nonlinear regression and
MCMC), and generates the plots from the paper.
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